Detalles de la búsqueda
1.
Regional variation in cause of death in patients with type 2 diabetes: Insights from EXSCEL.
Am Heart J
; 271: 123-135, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38395292
2.
Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial.
J Vasc Surg
; 75(2): 660-670.e3, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34597783
3.
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial.
Vasc Med
; 27(1): 21-29, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516308
4.
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial.
Vasc Med
; 26(6): 608-612, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34082620
5.
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
N Engl J Med
; 376(1): 32-40, 2017 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27959717
6.
Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial.
Am Heart J
; 220: 51-58, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31783279
7.
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
JAMA
; 324(22): 2268-2280, 2020 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33190147
8.
Stroke in Patients With Peripheral Artery Disease.
Stroke
; 50(6): 1356-1363, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31092165
9.
Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
Vasc Med
; 24(5): 422-430, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31339474
10.
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
Circulation
; 135(3): 241-250, 2017 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27840336
11.
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.
Eur J Vasc Endovasc Surg
; 55(1): 109-117, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29273390
12.
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Vasc Med
; 23(6): 523-530, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29992857
13.
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial.
Am Heart J
; 175: 86-93, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27179727
14.
CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial.
Am Heart J
; 229: 118-120, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32950849
15.
Understanding Study Drug Discontinuation Through EUCLID.
Front Cardiovasc Med
; 9: 947645, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35928933
16.
Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial.
Atherosclerosis
; 338: 1-6, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741929
17.
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.
J Am Heart Assoc
; 10(12): e018684, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34056910
18.
Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization: Observations From the EUCLID Trial.
Circ Cardiovasc Interv
; 14(7): e009871, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253048
19.
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial.
Int J Chron Obstruct Pulmon Dis
; 16: 841-851, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33824584
20.
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial.
JAMA Cardiol
; 2021 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33993205